Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 10,455 | 422 | 0 | 0 | 0 |
| Gross Profit | 10,455 | 422 | N/A | N/A | N/A |
| Operating Expenses | 26,366 | 23,400 | 32,820 | 47,145 | 57,940 |
| Operating Income | -15,911 | -22,978 | -32,820 | -47,145 | -57,940 |
| Other Income | -319 | -785 | -1,695 | -1,062 | 36 |
| Pre-tax Income | -16,230 | -23,763 | -34,515 | -48,207 | -57,904 |
| Income Tax | N/A | N/A | N/A | N/A | -49 |
| Net Income Continuous | -16,230 | -23,763 | -34,515 | -48,207 | -57,855 |
| Minority Interests | -6 | -160 | N/A | N/A | N/A |
| Net Income | $-16,224 | $-23,603 | $-34,515 | $-48,207 | $-57,855 |
| EPS Basic Total Ops | -1.77 | -7.03 | -16.11 | -26.13 | -34.17 |
| EPS Basic Continuous Ops | -1.77 | -7.08 | -16.11 | -26.13 | -34.22 |
| EPS Diluted Total Ops | -1.77 | -7.03 | -16.11 | -26.13 | -34.17 |
| EPS Diluted Continuous Ops | -1.77 | -7.08 | -16.11 | -26.13 | -34.22 |
| EPS Diluted Before Non-Recurring Items | -1.77 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-14,189 | $-21,189 | $-31,369 | $-45,828 | $-56,336 |